- Home
- CDNA vs MBWM Comparison
CDNA vs MBWM Comparison
Compare CDNA & MBWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- MBWM
- Stock Information
- Founded
- CDNA 1998
- MBWM 1997
- Country
- CDNA United States
- MBWM United States
- Employees
- CDNA N/A
- MBWM N/A
- Industry
- CDNA Medical Specialities
- MBWM Major Banks
- Sector
- CDNA Health Care
- MBWM Finance
- Exchange
- CDNA Nasdaq
- MBWM Nasdaq
- Market Cap
- CDNA 712.2M
- MBWM 763.4M
- IPO Year
- CDNA 2014
- MBWM 1997
- Fundamental
- Price
- CDNA $13.82
- MBWM $48.68
- Analyst Decision
- CDNA Buy
- MBWM Buy
- Analyst Count
- CDNA 7
- MBWM 4
- Target Price
- CDNA $27.67
- MBWM $53.63
- AVG Volume (30 Days)
- CDNA 1.5M
- MBWM 53.1K
- Earning Date
- CDNA 11-03-2025
- MBWM 10-14-2025
- Dividend Yield
- CDNA N/A
- MBWM 3.04%
- EPS Growth
- CDNA N/A
- MBWM N/A
- EPS
- CDNA 1.00
- MBWM 5.03
- Revenue
- CDNA $340,826,000.00
- MBWM $228,384,000.00
- Revenue This Year
- CDNA $13.02
- MBWM $10.34
- Revenue Next Year
- CDNA $12.85
- MBWM $11.93
- P/E Ratio
- CDNA $13.85
- MBWM $9.68
- Revenue Growth
- CDNA 14.72
- MBWM 3.70
- 52 Week Low
- CDNA $10.96
- MBWM $37.76
- 52 Week High
- CDNA $32.97
- MBWM $52.98
- Technical
- Relative Strength Index (RSI)
- CDNA 54.96
- MBWM 55.23
- Support Level
- CDNA $12.37
- MBWM $48.35
- Resistance Level
- CDNA $14.20
- MBWM $49.45
- Average True Range (ATR)
- CDNA 0.73
- MBWM 1.22
- MACD
- CDNA 0.27
- MBWM 0.08
- Stochastic Oscillator
- CDNA 87.02
- MBWM 64.12
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About MBWM Mercantile Bank Corporation
Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.